Quantcast

Latest Psoriatic arthritis Stories

2010-01-25 15:03:00

$1.5 million approved for CDC in 2010 federal appropriations bill WASHINGTON, Jan. 25 /PRNewswire-USNewswire/ -- Thousands of Oregonians suffering from psoriasis and psoriatic arthritis got a boost for the new year from the federal government when it approved $1.5 million to launch the first-ever psoriasis patient registry at the Centers for Disease Control (CDC). The approval of the $1.5 million by Congress was realized after months of advocacy by Oregon lawmakers, U.S. Rep. David Wu...

2010-01-07 11:57:00

$1.5 million approved for CDC in 2010 federal appropriations bill WASHINGTON, Jan. 7 /PRNewswire-USNewswire/ -- Millions of Americans suffering from psoriasis and psoriatic arthritis got a year-end boost from the federal government when it approved $1.5 million for the first-ever psoriasis patient registry at the Centers for Disease Control (CDC). By aggregating data from the profiles of thousands of people with psoriatic disease, the patient registry will provide much-needed insight...

2009-10-29 04:00:00

National Psoriasis Foundation asks Americans affected by psoriatic diseases to take action PORTLAND, Ore., Oct. 29 /PRNewswire-USNewswire/ -- Today is World Psoriasis Day and the National Psoriasis Foundation is asking all Americans affected by psoriasis and psoriatic arthritis to raise awareness about these diseases by going to www.psoriasis.org/wpd and taking action. Psoriasis, a painful and disfiguring autoimmune disease that appears on the skin, affects an estimated 125 million...

2009-10-22 09:39:00

KENSINGTON, Md., Oct. 22 /PRNewswire-USNewswire/ -- The first-ever North Carolina Psoriasis Walk will take place this Saturday, Oct. 24, in Charlotte's beautiful Freedom Park. The walk, to support the research and education programs of the nonprofit Psoriasis Cure Now, will include entertainment, information booths on psoriasis treatments, and a chance to meet and learn from others living with psoriasis and psoriatic arthritis. More information is available at...

2009-10-20 06:00:00

Minorities experience more severe disease and greater emotional and social distress than their Caucasian peers PORTLAND, Ore., Oct. 20 /PRNewswire-USNewswire/ -- Data from a comprehensive survey of nearly 5,000 people with psoriasis and psoriatic arthritis reveal that African Americans, Asians and Latinos are more likely than Caucasians to suffer psychological effects from the diseases. The study also found very severe disease to be more common among members of these groups. Psoriasis...

2009-10-19 07:02:00

PHILADELPHIA, Oct. 19 /PRNewswire/ -- Phase 3 data reported for the first time show that once every four week subcutaneous injections of SIMPONI(TM) (golimumab) resulted in significantly greater inhibition of structural damage compared with placebo plus methotrexate in patients with active rheumatoid arthritis (RA) and active psoriatic arthritis (PsA). Radiographic analyses showed that treatment with SIMPONI resulted in a statistically significant reduction in change from baseline in...

2009-10-16 06:00:00

KENSINGTON, Md., Oct. 16 /PRNewswire-USNewswire/ -- The first-ever Maryland Psoriasis Walk will take place tomorrow in Baltimore's Inner Harbor. The walk, to support the research and education programs of the nonprofit Psoriasis Cure Now, will include entertainment, information booths on psoriasis treatments, and a chance to meet and learn from others living with psoriasis and psoriatic arthritis. More information is available at http://www.PsoriasisWalkMD.org . "Psoriasis can strike at...

2009-10-13 04:00:00

People on immunosuppressants should receive vaccines and take extra precaution PORTLAND, Ore., Oct. 13 /PRNewswire-USNewswire/ -- People with psoriasis and/or psoriatic arthritis who are taking biologic or non-biologic immunosuppressive medications should receive the inactived forms of both seasonal influenza and H1N1 (swine flu) vaccines as soon as possible, according to a recommendation from the National Psoriasis Foundation. The National Psoriasis Foundation's medical experts...

2009-10-06 10:14:00

HORSHAM, Pa. and KENILWORTH, N.J., Oct. 6 /PRNewswire/ -- Centocor Ortho Biotech Inc. and Schering-Plough Corporation (NYSE: SGP) announced today that the European Commission has approved SIMPONI(TM) (golimumab) as a once-monthly, subcutaneous therapy for the treatment of moderate-to-severe, active rheumatoid arthritis (RA), active and progressive psoriatic arthritis (PsA) and severe, active ankylosing spondylitis (AS). In the European Union, SIMPONI is approved as a 50 mg subcutaneous...

2009-10-01 06:00:00

Two-thirds of women with psoriasis say the disease negatively affects their overall emotional well-being PORTLAND, Ore., Oct. 1 /PRNewswire-USNewswire/ -- Women with psoriasis and psoriatic arthritis are markedly more likely than men to suffer from the emotional and psychological effects of the diseases, according to survey data released by the National Psoriasis Foundation today. Psoriasis is the most prevalent autoimmune disease in the country, affecting as many as 7.5 million...


Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related